Encouraged by the robust inhibitory effects of IRF/H-GDz/Ca MNF materials in gastric cancer cell experiments, their tumor-targeting specificity and anti-tumor efficacy were further evaluated in vivo. The gene discussed is TRIM63; the disease is gastric cancer.